THE SKINNY  
 
  ADVANCES IN VELASMOOTH
from the Winter 2007 issue

In June 2005, the FDA granted clearance to the VelaSmooth™ medical device to be marketed for temporary reduction in the appearance of cellulite. In September 2006, Syneron Medical Ltd., the manufacturer and distributor of the VelaSmooth, introduced the new Contour Applicator™, a smaller, versatile treatment head for the VelaSmooth System. The new applicator can be used in combination with the original Body Applicator™ to further enhance the effects of the cellulite reduction therapy. The Contour Applicator can target the chin, knees, “love handles” around the waist, and other hard-to-get areas, such as the arms, neck, bra line and back of the calves.

The VelaSmooth treatment utilizes four different modalities to achieve reduction of cellulite: conducted bipolar radio frequency, infrared light, massage and suction. The radio frequency and infrared light heat the fat tissue, and the massage and suction help to mobilize trapped fluid from the fat. This results in a smoother, less-dimpled surface. Many patients describe the treatment as an intense deep-tissue massage.

The areas most commonly treated are the abdomen, thighs, hips and buttocks. Generally, more treatments translate to better results, so we offer packages of eight treatments (once a week for eight weeks). Each treatment lasts 30 to 60 minutes, depending on the surface area being treated. Maintenance treatments are recommended once every four to six weeks. We also offer a Signature VelaSmooth, which starts with a vibradermabrasion to exfoliate the outer most layer of your skin. This exfoliation helps the VelaSmooth deliver the heat to the treatment areas more quickly. We complete the treatment with GentleWaves® to boost your treatment and help with collagen production, sun damage and elasticity.

One of the first published studies of VelaSmooth was in 2004 in the Journal of Cosmetic Laser Therapeutics. In that study conducted on 35 women with cellulite, all study patients showed some level of reduction in thigh circumference after eight weeks of treatment. The mean decrease in circumference was 0.8 inches, and some patients had reductions of more than two inches. All patients showed some level of improvement in skin texture and cellulite. About 23 percent reported “excellent” or “very good” improvement, 35 percent of results were “good” and 42 percent showed “mild” improvement. Analysis of pre- and post-study digital photographs revealed an average 40 percent improvement in the cellulite.
   

So is VelaSmooth right for you, set up a consultation, and we’ll let you know if you are a good candidate. Got questions, contact one of our patient care coordinators at 713.850,0240.

For more information, see:

VelaSmooth: The Medical
Cellulite Solution

Winter 2005
 
 
 
WELCOME SERVICES THE SKINNY APPOINTMENTS PRODUCTS ABOUT US CALENDAR CLINICAL TRIALS CONTACT US